TABLE 5.
Tonsil and oropharyngeal squamous cell carcinoma survival outcomes and prognostic factors.
| Author | Year | Treatment | No. of patients | Site | 5-y OS % | 5-y DSS % | 5-y RFS % | Nodal status | LVI | HPV |
|---|---|---|---|---|---|---|---|---|---|---|
| Current study | 2012 | Surgery | 88 | Tonsil | 66 | 82 | 80 | NS | S | S |
| Moore26 | 2009 | Surgery | 102 | Tonsil | 85 | 94 | – | – | – | – |
| Yildirim27 | 2010 | Surgery | 120 | Tonsil | 86 | – | 92 | – | – | – |
| Chuang28 | 2011 | Surgery | 86 | Tonsil | – | – | – | S for DSS | NS | NS |
| Hicks7 | 1998 | Surgery vs nonsurgical | 90 | Tonsil | – | 61/37 | – | – | – | – |
| Perez31 | 1998 | Surgery vs nonsurgical | 384 | Tonsil | NS | – | – | S for DFS | – | – |
| Poulsen9 | 2007 | Surgery vs nonsurgical | 146 | Tonsil | 65/41 | 75/56 (NS) | – | NS | – | – |
| Shirazi32 | 2006 | Surgery vs nonsurgical | 74 | Tonsil | 71/48 (NS) | – | – | S | – | – |
| Jaber8 | 2009 | Surgery vs nonsurgical | 141 | Tonsil | 45/23 | 67/30 | – | NR | – | – |
| Mendenhall29 | 2000 | RT | 400 | Tonsil | 49 | 70 | – | NS | – | – |
| Setton10 | 2012 | CRT | 221 | OP | 86 | – | – | S for OS | – | – |
| Denis30 | 2004 | RT vs CRT | 226 | OP | 22 | 27 | – | NR | – | – |
| Mendenhall29 | 2010 | RT | 130 | OP | 76 | 85 | – | NR | – | – |
| Fein33 | 1996 | RT | 490 | OP | 44 | 77 | – | NR | – | – |
| Moncrieff34 | 2009 | Surgery | 92 | OP | – | 83 | – | NS | – | – |
| Haughey16 | 2011 | Surgery | 204 | OP | 78 | 84 | 74 | NS | – | S |
| Haughey17 | 2012 | Surgery | 171 | OP | 91 | 94 | – | NS | S | S |
Abbreviations: OS, overall survival; DSS, disease-specific survival; RFS, recurrence-free survival; LVI, lymphovascular invasion; HPV, human papillomavirus; NS, not significant; S, significant; DFS, disease-free survival; NR, not reported; RT, radiotherapy; CRT, chemoradiation; OP, oropharynx.